Andries Van Schuerbeek

Research activity per year

If you made any changes in Pure these will be visible here soon.

The synthetic ghrelin receptor agonist MK0677 increases mesolimbic/mesocortical dopamine release following local administration in the ventral tegmental area without affecting anxiety or cued fear extinction
Anouk Pierre (Speaker), Andries Van Schuerbeek (Speaker), Wissal Allaoui (Speaker), Eva-Maria Fritz (Contributor), Nicolas Singewald (Contributor), tom beckers (Contributor), Ann Van Eeckhaut (Speaker), Ilse Smolders (Speaker) & Dimitri De Bundel (Speaker)
21 May 2019
Activity: Talk or presentation › Talk or presentation at a conference
11th FENS Forum of Neuroscience
Andries Van Schuerbeek (Participant)
7 Jul 2018 → 11 Jul 2018
Activity: Participating in or organising an event › Participation in conference
Research stay (France)
Andries Van Schuerbeek (Participant)
16 Jan 2017 → 14 Apr 2017
Activity: Other › Research and Teaching at External Organisation

Activities